G
o
o
g
l
e
×
Please click
here
if you are not redirected within a few seconds.
All
Images
News
Books
Maps
Videos
Shopping
Search tools
Past week
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Clear
Recursion Pharmaceuticals (RXRX) Reports Q3 Loss, Misses Revenue Estimates
Yahoo Finance
Recursion Pharmaceuticals (RXRX) delivered earnings and revenue surprises of -3.03% and 24.86%, respectively, for the quarter ended September 2024.
1 day ago
Is Recursion Pharmaceuticals a Millionaire-Maker Stock?
The Motley Fool
In an environment where the typical small biotech name is riskier than not, this one is curiously different.
5 days ago
Recursion Provides Business Updates and Reports Third Quarter 2024 Financial Results
Stock Titan
Recursion reports strong Q3 growth with revenue up 148% YoY, secures major Roche-Genentech partnership, and advances clinical pipeline while expanding...
1 day ago
Recursion’s REC-1245 IND Cleared by FDA for Phase 1/2 Trial
The Healthcare Technology Report.
Recursion, a clinical-stage TechBio company leveraging AI for drug discovery, has announced that the FDA has cleared an investigational new drug (IND)...
1 day ago
Recursion Studio: Professional Visuals for Live Performers
Gearnews.com
Recursion Studio by Entropy & Sons is an unusual new instrument that uses video synthesis to create images from audio signals.
3 days ago
Peering Into Recursion Pharmaceuticals's Recent Short Interest
Benzinga
Recursion Pharmaceuticals's. RXRX+2.67%. Get Free Report. short percent of float has fallen 25.69% since its last report. The company recently reported that...
3 days ago
Recursion Pharmaceuticals: Q3 Earnings Snapshot
San Francisco Chronicle
SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Wednesday reported a loss of $95.8 million in its third quarter.
1 day ago
Exscientia Plc Enhances Board Collaboration with Recursion
TipRanks
Exscientia Plc (EXAI) has released an update. Exscientia Plc has announced a key amendment to its transaction agreement with Recursion Pharmaceuticals,...
1 day ago
Recursion Pharmaceuticals Inc (RXRX) Q3 2024 Earnings Report Pre
GuruFocus
Recursion Pharmaceuticals Inc (RXRX) is set to release its Q3 2024 earnings on Nov 6, 2024. The consensus estimate for Q3 2024 revenue is $29.84 million,...
1 day ago
Recursion Pharmaceuticals: Q3 Earnings Snapshot
Barchart.com
SALT LAKE CITY (AP) — SALT LAKE CITY (AP) — Recursion Pharmaceuticals Inc. (RXRX) on Wednesday reported a loss of $95.8 million in its third quarter.
1 day ago